BHVN
Biohaven Ltd.
Next earnings Aug 10, 2026 · consensus $-0.73 EPS, $546K rev
Last earnings +2.4% on 2026-05-04
$15.83
▲ +3.19%$15.83▲ +12.35%
over 1Y
L $7.95EODHDH $18.11
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.2%
1W+3.2%
1M+40.2%
3M+89.1%
YTD+46.0%
1Y+12.3%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 25 analysts
Buy
High leverage (liabilities/equity 7.7x).
Return on equity -1418.8% · latest
Biohaven Ltd. shows limited reported revenue, and -1418.8% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$219M | -$568M | -$436M | -$885M | -$745M |
| Net income | -$214M | -$570M | -$408M | -$846M | -$739M |
| Diluted EPS | -$5.43 | -$12.75 | -$5.73 | -$9.28 | -$6.86 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$2.15B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-31.0%
FCF yield-25.6%
Quality & risk
ROIC (est.)-1130.8%
Free cash flow-$610M
Total debt—
Net cash$230M
Piotroski F-Score1/6
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+47.4%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRoutine disclosure cadence — no material red flags in recent filings.
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-05-262026-05-27open ↗SCHEDULE 13G/AFiling2026-05-15open ↗8-KPeriod ending 2026-05-042026-05-05open ↗424B5Filing2026-05-04open ↗S-3ASRFiling2026-05-04open ↗10-QPeriod ending 2026-03-312026-05-04open ↗8-KPeriod ending 2026-05-042026-05-04open ↗8-KPeriod ending 2026-04-282026-05-04open ↗4Period ending 2026-04-282026-04-30open ↗4Period ending 2026-04-282026-04-30open ↗4Period ending 2026-04-282026-04-30open ↗4Period ending 2026-04-282026-04-30open ↗
Frequently asked
- Is Biohaven Ltd. (BHVN) a buy?
- BHVN currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. High leverage (liabilities/equity 7.7x).
- What is Biohaven Ltd.'s quality score?
- BHVN scores 48.07692307692307/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001935979, latest 10-Q filed 2026-05-04) · EODHD · as of 6/26/2026, 5:52:34 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.